Bioretec earned the FDA's breakthrough device designation for its RemeOs spinal interbody cage, the company said March 14.
RemeOs is designed to restore intervertebral height and facilitate cervical spinal fusion, according to a news release.
With breakthrough designation Bioretec will look into accelerating development of RemeOs.